Stevanato Group S.p.A. (STVN) is a publicly traded Healthcare sector company. As of May 21, 2026, STVN trades at $17.75 with a market cap of $4.86B and a P/E ratio of 0.00. STVN moved +2.42% today. Year to date, STVN is -15.68%; over the trailing twelve months it is -27.01%. Its 52-week range spans $12.89 to $28.00. Analyst consensus is strong buy with an average price target of $26.07. Rallies surfaces STVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes STVN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $17.75 |
| Market Cap | $4.86B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.05% |
| 52-Week High | $28.00 |
| 52-Week Low | $12.89 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover STVN: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $26.07.